Tandem Diabetes Care (NSDQ:TNDM) announced today that it began the U.S. commercial launch of its t:slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology. In December, the San Diego-based company announced that the FDA cleared the t:slim X2 insulin pump and Control-IQ technology for controlling Type 1 diabetes, touting it as the first and only system cleared […]
Drug-Device Combinations
TriSalus launches TriNac Infusion System
TriSalus this week launched its TriNac Infusion System. The infusion system is powered by the company’s Pressure-Enabled Drug Delivery (PEDD) approach with SmartValve technology and is designed to help with the infusion barriers that can limit therapeutic uptake in solid tumors. It gives interventional radiologists intravascular tumor access and improved traceability, compatibility with standard angiographic catheters. […]
7 medtech advances to improve diabetes treatment
Medtech and pharmaceutical companies have made several important strides over the past year when it comes to improving diabetes treatment. Multiple treatments and technologies have cleared regulatory hurdles and are now hitting the market and making the process of living with diabetes that much more manageable. Several different styles of therapy and devices have come […]
Dyve Biosciences hires new chief scientific officer
Transdermal drug therapy developer Dyve Biosciences announced that it appointed longtime Pfizer executive Chuck Harbert to the role of chief scientific officer. Harbert spent three decades at Pfizer, serving as the company’s VP of U.S. exploratory development and strategic planning, among other senior positions with Pfizer Central Research. He is the inventor and co-inventor of […]
Medinol stent performs just as well as Medtronic Resolute, study says
The EluNIR drug-eluting stent made by Medinol performed just as well as the Resolute Integrity or Resolute Onyx stents from Medtronic (NYSE:MDT), according to new clinical study results from an international team of researchers. The randomized clinical trial — conducted by researchers from the U.S., Israel, Canada and the Netherlands — involved 2,221 people and compared […]
MD&M West exhibitors you need to know
MD&M West — set for Feb. 11-13, 2020 — is billed as the largest medical device manufacturing event in the world. Now in its 35th year, it showcases hundreds of industry suppliers and attracts thousands of medical device industry insiders. Strolling around the show floor at the Anaheim Convention Center, in Anaheim, Calif., visitors will see […]
The 10 greatest medtech advances of the 2010s
From disposable endoscopes to TAVR to robotic surgery, there’s a whole host of medtech advances widely available now that weren’t around much 10 years ago. “In terms of technological advances, I would put this past decade as one of the most important for medical technology. From connected devices and robotics, to advances in material sciences […]
Delcath Systems announces reverse stock split
A reverse stock split went into effect today for Delcath Systems (OTC:DCTH) — developer of the Chemostat hepatic delivery system for treating cancer. The 1-for-700 reverse stock split is meant to reduce the number of common stock shares and shares reserved for issuance to 1.2 million, from a previous 1.4 billion. The authorized number of shares […]
Smiths Medical recalls Medfusion 4000 due to issue with software update
Smiths Medical has recalled its Medfusion 4000 syringe pump with Firmware version 1.7.0 due to malfunctioning alarms and potential interruption of therapy, FDA said today. The FDA has labeled the recall as Class I, it’s most serious designation. The Medfusion 4000 syringe pump is designed to deliver blood, blood products or prescribed drugs into a […]
Teleflex warns on Arrow EZ-IO needle sets
Teleflex (NYSE:TFX) today issued a safety warning in the United Kingdom for its Arrow EZ-IO intraosseous vascular access needle sets due to a risk of needle stick injury. The company informed users that they should not use the affected needles if the safety cap is not in place, due to a risk of needle stick […]
Q Biomed raises combined $1.5 million
Q Biomed has raised a total of $1.5 million in equity, debt and options/warrants or other rights to acquire another security, according to two separate filings with the Securities & Exchange Commission. The New York-based company filed both forms on Dec. 13. Q Biomed completed one $500,000 offering and sold $1 million of a $3 […]